nice news again
$$$ no problem wait $$$

7´s are coming

GO SIRG
happy new years are coming

thx warren
GO SIRG

that´s absolutly nonsens!!!

up and down , up and down

absolutly Salty

that´s absolutly correct josey
go SIRG

oh no no no 2 dollar ?????

now we have a half dollar CRAZY
i can´t understand it

my last 10k shares i had buy for 79 cent
wait wait wait dollar´s are coming

70´s are coming back today ...

isn´t a good start this week..

we are ready
SIRG are ready
stay tuned and good luck to all SIRG pirates

but it must be more

trit is more than 3 $ - share!
i hope the price is going up

i don´t know !
maybe, next year we have 5 $ on the board
i sell no one share

sellers are crazy
What´s up with us?
isn´t christmas to make presents in the 60 cents

news about celm?
what´s up?

yes and it´s time
go SNGX

0,6899 $ are gone
ask is very thin
dollars are coming

only 10000 shares and we have 0,79 $
climbing the ask buyers are coming

you could , if you buy 1000000 shares from SIRG

yes we go
SIRG

only 3768 shares on 0,65$
then we have 10000 on 0,69$

you are right
who is selling 5k ? i think no one
it must be a trick from the mm´s

hit again 0,0001
how much shares we have @ 0,0002 ?
thx for a answer

if we have no risks - then we are over 20 cents for a share in this moment

and it comes 2013 and we have millions of reasons why we are invested in SIERRA RESOURCE GROUP INC.
GO SIRG

good news again
break the 70 cent´s today ?

I AGREE GOOD POST

YOU ARE HERE: Stocks » Quotes and Charts » Barchart Opinion NEWS:
Soligenix Inc reports grant of US patent 8,263,582 for topically active steroids to treat inflammatory gastrointestinal disorders M2 - Fri Sep 14, 4:15AM CDTS4.96 -0.22
F9.79 -0.14 BAC8.95 -0.01
NOK2.60 -0.16 SIRI2.65 +0.08
RIMM8.24 +0.38

+ Portfolio
Soligenix Inc. (SNGX)
0.6800+0.0300 (+4.62%) 12:19P EST (OTC-BB) -
Detailed Opinion as of Tuesday, Oct 2nd, 2012
Detailed OpinionShow Signal Strength and Direction
Composite Indicators Signal
TrendSpotter Buy

Short Term Indicators
7 Day Average Directional Indicator Buy
10 - 8 Day Moving Average Hilo Channel Buy
20 Day Moving Average vs Price Buy
20 - 50 Day MACD Oscillator Buy
20 Day Bollinger Bands Buy

Short Term Indicators Average: 100% Buy
20-Day Average Volume - 15,839

Medium Term Indicators
40 Day Commodity Channel Index Buy
50 Day Moving Average vs Price Buy
20 - 100 Day MACD Oscillator Buy
50 Day Parabolic Time/Price Buy

Medium Term Indicators Average: 100% Buy
50-Day Average Volume - 10,799

Long Term Indicators
60 Day Commodity Channel Index Buy
100 Day Moving Average vs Price Buy
50 - 100 Day MACD Oscillator Buy

Long Term Indicators Average: 100% Buy
100-Day Average Volume - 9,828

Overall Average: 100% Buy

Price Support Pivot Point Resistance
0.6800 0.2900 0.5600 0.8300

it can be a reason for the running again
can we see 1 dollar in this month?
i would say YES WE CAN

let it run
go SNGX

it goes UP again

nice to see

that´s the right sight
go SIRG

yes
SIRG

here we have it
Soligenix, Inc. - Product Pipeline Review - 2012 New Report

Forward
Print
Save
Share on facebook Share on twitter Share on email Share on print More Sharing Services
0
Naperville, IL -- (SBWIRE) -- 09/27/2012 -- Soligenix, Inc. - Product Pipeline Review - 2012” provides data on the Soligenix, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- Soligenix, Inc. - Brief Soligenix, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Soligenix, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Soligenix, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Soligenix, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Soligenix, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Soligenix, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Soligenix, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Soligenix, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Soligenix, Inc. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Soligenix, Inc.; Soligenix, Inc. - Key Therapeutics; Soligenix, Inc. - Pipeline Overview and Promising Molecules; Soligenix, Inc. - News; Soligenix, Inc. - Latest Updates; Soligenix, Inc. - Pipeline; Soligenix, Inc. - Discontinued/Dormant Projects

To view table of contents for this market report please visit:
http://www.reportstack.com/product/90010/soligenix-inc-product-pipeline-review-2012.html

bid is climbing again